Clinical Trial Update: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of Choline Magnesium Trisalicylate in combination chemotherapy for various adult acute myeloid leukemia subtypes; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Choline Magnesium Trisalicylate (Choline magnesium trisalicylate)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 2 | Status: COMPLETED | Results posted: 2018-07-24